Recent Episodes
Understanding and Treating LGBTQI+ Patients with Cancer
Chasity Burrows Walters, PhD, RN, Memorial Sloan Kettering Cancer Center, New York, NY
Chronic Myeloid Leukemia: What HCPs Need to Know
Ehab Atallah, MD, Medical College of Wisconsin, Milwaukee, WI
2022 ASH Annual Meeting: Highlights from the Perspective of a Conference Attendee
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Understanding Waldenström Macroglobulinemia
Shayna Sarosiek, MD, Dana Farber Cancer Institute, Boston, MA
CAR T-cell Therapy in Review 2022: Updates in Treatment
Sattva S. Neelapu, MD, M.D. Anderson Cancer Center, Houston, TX
Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part II
Daphne Friedman, MD, Durham VA Health Care System, Durham, NC
Categories
- All Episodes (92)
- CAR T-cell Therapy (10)
- Clinical Trials (4)
- COVID-19 (7)
- General Treatment & Support (31)
- Genomics (3)
- Health Equity (7)
- Leukemia (22)
- Lymphoma (13)
- Minimal Residual Disease (MRD) (4)
- Myelodysplastic Syndromes (5)
- Myeloma & Amyloidosis (12)
- Myeloproliferative Neoplasms (3)
- Pediatric and AYA (12)
- Rare Blood Cancers (4)
- Transplantation (4)
- Waldenström macroglobulinemia (2)
